These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23484614)

  • 21. Treatment of gonorrhoea in Auckland, New Zealand: marked variation in prescriber adherence to treatment guidelines.
    Forster R; Ng D; Upton A; Franklin R; Thomas M
    Intern Med J; 2017 Jun; 47(6):640-648. PubMed ID: 28345188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of gonorrhea in Copenhagen and Frederiksberg].
    Wildt S; Danielsen AG; Friis-Møller A
    Ugeskr Laeger; 2003 Oct; 165(44):4224-7. PubMed ID: 14621556
    [No Abstract]   [Full Text] [Related]  

  • 23. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The rise in fluoroquinolone-resistant Neisseria gonorrhoeae among people attending the Municipal Health Service's clinic for sexually transmitted diseases in Amsterdam, the Netherlands; cefotaxime now first-choice treatment for uncomplicated gonorrhoea].
    Kolader M; Peerbooms PG; Vader PC; van Bergen JE; Fennema JS; de Vries HJ
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2129-32. PubMed ID: 15553358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annual report of the Australian Gonococcal Surveillance Programme, 1998.
    Commun Dis Intell; 1999 Jul; 23(7):193-7. PubMed ID: 10476608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
    Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UK national guideline for the management of gonorrhoea in adults, 2011.
    Bignell C; Fitzgerald M; ;
    Int J STD AIDS; 2011 Oct; 22(10):541-7. PubMed ID: 21998172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
    Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
    Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual report of the Australian Gonococcal Surveillance Programme, 1997.
    Commun Dis Intell; 1998 Oct; 22(10):212-6. PubMed ID: 9803596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
    Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
    J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--national resistance prevalence in 2007 and 2008, and trends during 2005-2008.
    Kubanova A; Frigo N; Kubanov A; Sidorenko S; Lesnaya I; Polevshikova S; Solomka V; Bukanov N; Domeika M; Unemo M
    Euro Surveill; 2010 Apr; 15(14):. PubMed ID: 20394716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-line treatment with ceftriaxone for
    Durban E; English K; Evans R; Martin S
    Sex Health; 2024 Jul; 21():. PubMed ID: 39008622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoroquinolone resistance among Neisseria gonorrhoeae isolates from Shanghai, China: detection of quinolone resistance-determining region mutations.
    Tiejun Z; Xiaoming Z; Jilun Z; Yinghu Z; Yanhua R; Yue C; Weiming G; Tao Z; Qingwu J
    Indian J Med Res; 2009 Jun; 129(6):701-6. PubMed ID: 19692753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece.
    Tzelepi E; Avgerinou H; Flemetakis A; Siatravani E; Stathi M; Daniilidou M; Miriagou V
    Sex Transm Dis; 2010 Feb; 37(2):115-20. PubMed ID: 19901866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility pattern of Neisseria gonorrhoeae in western Austria.
    Allerberger F; Kofler H; Brezinka C; Guggenbichler JP; Dierich MP
    Wien Klin Wochenschr; 1993; 105(12):346-9. PubMed ID: 8333204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practice alert: CDC no longer recommends quinolones for treatment of gonorrhea.
    Campos-Outcalt D
    J Fam Pract; 2007 Jul; 56(7):554-8. PubMed ID: 17605948
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of multiresistant strains of Neisseria gonorrhoeae isolated in Nicaragua.
    Castro I; Bergeron MG; Chamberland S
    Sex Transm Dis; 1993; 20(6):314-20. PubMed ID: 8108753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.